COMMUNIQUÉS West-GlobeNewswire

TiGenix to present positive 52-week Phase III results of Cx601 at World Congress of Gastroenterology at ACG 2017 meeting

05/10/2017 - 07:00

PRESS RELEASE TiGenix to present positive 52-week Phase III results of Cx601 at World Congress of Gastroenterology at ACG 2017 meeting Leuven (BELGIUM) - October 5, 2017, 07:00h CET - TiGenix NV (Euronext Brussels and [...]

TiGenix présentera les résultats favorables de la semaine 52 de l'essai de phase III de Cx601 à l'occasion du Congrès Mondial de Gastro-entérologie à ACG 2017

05/10/2017 - 07:00

COMMUNIQUÉ DE PRESSE TiGenix présentera les résultats favorables de la semaine 52 de l'essai de phase III de Cx601 à l'occasion du Congrès Mondial de Gastro-entérologie à ACG 2017 Louvain (BELGIQUE) - 5 octobre 2017, [...]

PCI Biotech receives US Orphan Drug Designation for fimaporfin in the treatment of bile duct cancer (cholangiocarcinoma)

04/10/2017 - 17:59

Oslo, 4 October 2017 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its lead product [...]

Abeona Therapeutics Announces Dedication of Commercial Gene Therapy Manufacturing Facility in Cleveland, Ohio

04/10/2017 - 14:51

-- Facility to support development of advanced gene and cell therapies for treatment of life-threatening rare diseases -- Leaders from local government, life sciences and medical technology to join on October 4 for [...]

EDAP Announces FDA Clearance of its Ablatherm-Fusion® device

04/10/2017 - 14:15

LYON, France, October 4, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced FDA approval of its Ablatherm-Fusion device enabling a more precise method for targeting of [...]

Immunocore Appoints Andrew Hotchkiss as Chief Commercial Officer

04/10/2017 - 13:00

PRESS RELEASE Immunocore Appoints Andrew Hotchkiss as Chief Commercial Officer (Oxford, UK and Conshohocken, US, 4 October 2017) Immunocore Limited, the world's leading TCR company developing biological drugs to treat [...]

Summit Highlights DMD Biomarker Validation Data at 22nd WMS Congress

04/10/2017 - 13:00

Summit Therapeutics plc ('Summit', or 'the Company') SUMMIT HIGHLIGHTS DMD BIOMARKER VALIDATION DATA AND PHASE 2 CLINICAL TRIAL BASELINE CHARACTERISTICS IN PRESENTATIONS AT 22ND WMS CONGRESS Oxford, UK, 4 October 2017 [...]

Zealand Pharma and Torrey Pines Institute for Molecular Studies announce research collaboration

04/10/2017 - 11:29

Press release - No. 8/2017 Zealand Pharma and Torrey Pines Institute for Molecular Studies announce research collaboration Combining expertise in discovery and development of peptide therapeutics with unique peptide [...]

Ambu A/S: Ambu launches ambitious strategy towards 2020

04/10/2017 - 10:58

After exceeding the goals of the 2017 strategy, Ambu sets new goals and aims to double revenue in just three years. The key elements are a stable core business and disruptive single-use endoscopy technology. In 2013, [...]

Immunocore Appoints Andrew Hotchkiss as Chief Commercial Officer

04/10/2017 - 08:00

PRESS RELEASE Immunocore Appoints Andrew Hotchkiss as Chief Commercial Officer (Oxford, UK and Conshohocken, US, 4 October 2017) Immunocore Limited, the world's leading TCR company developing biological drugs to treat [...]

XBiotech annonce l'ajout du dermatologue renommé, le Dr William Levis, à son Conseil scientifique consultatif

04/10/2017 - 02:48

AUSTIN, Texas, le 4 octobre 2017 (GLOBE NEWSWIRE). - XBiotech Inc. (NASDAQ : XBIT) est heureuse d'annoncer la nomination de William Levis, MD, à son Conseil scientifique consultatif (Scientific Advisory Board - SAB). Le [...]

KARO PHARMA AB'S TAKEOVER OFFER FOR WEIFA ASA SUCCESSFUL

03/10/2017 - 18:00

On expiration of the offer period on 3 October, 2017 at 16:30 CEST, Karo Pharma AB ("Karo Pharma") had received acceptances for the voluntary offer ("Voluntary Offer") to acquire all shares in Weifa ASA ("Weifa") for a [...]

NICOX : Nombre total de droits de vote au 30 septembre 2017

03/10/2017 - 17:45

Nicox SA Société anonyme au capital de 29 169 338 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 3 octobre 2017, PUBLICATION MENSUELLE DU NOMBRE D' [...]

NICOX : Number of voting rights as of September 30, 2017

03/10/2017 - 17:45

Nicox SA Société anonyme with a registered capital of € 29,169,338 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On October 3, 2017, MONTHLY PUBLICATION OF THE [...]

Targovax granted US Patent for mutant-RAS neoantigen platform 2nd generation product TG02

03/10/2017 - 14:48

Extends IP protection of TG02 in the US until 09.12.2034 Oslo, 3 October 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target [...]

Advanced Bifurcation Systems Announces Plan for Human Clinical Trials in New Brunswick, Canada

03/10/2017 - 13:55

LOS ANGELES, Oct. 03, 2017 (GLOBE NEWSWIRE) -- Advanced Bifurcation Systems ("ABS" or the "Company"), a clinical stage medical device company developing an innovative stenting platform which overcomes the limitations of [...]

RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

03/10/2017 - 13:39

BEKINDA ® i 12 mg Phase II study successfully met its primary endpoint, improving primary efficacy outcome of stool consistency by an absolute difference of 19.4% vs. placebo and comparing favorably with previously [...]

Shire plc : Director/PDMR Shareholding

03/10/2017 - 13:00

Director/PDMR Shareholding October 3, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by persons discharging managerial responsibilities 1. Details of the person discharging managerial [...]

Saniona AB: Saniona obtains research milestone from The Michael J. Fox Foundation for Parkinson's Research

03/10/2017 - 12:45

PRESS RELEASE October 3, 2017 Saniona, a leading biotech company in the field of ion channels, today announces that it has reached the third research milestone for identifying new drug candidates for the treatment of [...]